First Time Loading...
C

Caregen Co Ltd
KOSDAQ:214370

Watchlist Manager
Caregen Co Ltd
KOSDAQ:214370
Watchlist
Price: 21 350 KRW -1.16% Market Closed
Updated: May 10, 2024
Section:
 

Relative Value

The Relative Value of one Caregen Co Ltd stock under the Base Case scenario is 4 514.87 KRW. Compared to the current market price of 21 350 KRW, Caregen Co Ltd is Overvalued by 79%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
4 514.87 KRW
Overvaluation 79%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

13.2
P/S
P/S
Price to Sales
13.2
vs History
26
vs Industry
12
Median 3Y
4.2
Median 5Y
2.7
Industry
2.5
Forward
6.7
More Details
26.3
P/E
P/E
Price to Earnings
26.3
vs History
26
vs Industry
20
Median 3Y
9.9
Median 5Y
7.6
Industry
23.4
Forward
14.7
More Details
36.7
P/OCF
P/OCF
Price to OCF
36.7
vs History
12
vs Industry
12
Median 3Y
2.8
Median 5Y
2.8
Industry
17.4
More Details
55.5
P/FCFE
P/FCFE
Price to FCFE
55.5
vs History
12
vs Industry
11
Median 3Y
4.3
Median 5Y
4.3
Industry
23.6
More Details
4.6
P/B
P/B
Price to Book Value
4.6
vs History
26
vs Industry
16
Median 3Y
1.2
Median 5Y
0.7
Industry
2.1
More Details
11.6
EV/S
EV/S
Enterprise Value to Sales
11.6
vs History
26
vs Industry
13
Median 3Y
1.8
Median 5Y
0.1
Industry
2.6
Forward
5.9
More Details
15.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
15.7
vs History
26
vs Industry
12
Median 3Y
2.4
Median 5Y
0.1
Industry
5.2
More Details
20.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.2
vs History
26
vs Industry
19
Median 3Y
3.4
Median 5Y
0.2
Industry
13.7
Forward
9.4
More Details
22.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.7
vs History
26
vs Industry
21
Median 3Y
3.7
Median 5Y
0.2
Industry
17.2
Forward
10.1
More Details
32
EV/OCF
EV/OCF
Enterprise Value to OCF
32
vs History
12
vs Industry
15
Median 3Y
0.1
Median 5Y
-0.1
Industry
16.2
More Details
48.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
48.5
vs History
12
vs Industry
10
Median 3Y
0.2
Median 5Y
-0.1
Industry
17.8
More Details
8.1
EV/IC
EV/IC
Enterprise Value to IC
8.1
vs History
26
vs Industry
11
Median 3Y
1.4
Median 5Y
0.1
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Caregen Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Caregen Co Ltd
KOSDAQ:214370
1T KRW 13.2 26.3 20.2 22.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
733.3B USD 20.4 119.5 58.5 66.6
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.1 44.1 32.9 36.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
360.6B USD 4.2 9.4 11.5 15.1
US
Merck & Co Inc
NYSE:MRK
329.8B USD 5.4 143 35.6 58.2
UK
AstraZeneca PLC
LSE:AZN
191.2B GBP 5 37.8 174.6 278.5
CH
Roche Holding AG
SIX:ROG
177.2B CHF 3 15.4 8.8 10.4
CH
Novartis AG
SIX:NOVN
177.1B CHF 3.3 11.1 8.5 12.4
US
Pfizer Inc
NYSE:PFE
159.1B USD 2.9 -514.9 12.8 20.3
P/E Multiple
Earnings Growth
KR
C
Caregen Co Ltd
KOSDAQ:214370
Average P/E: 50.8
26.3
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
119.5
346%
DK
Novo Nordisk A/S
CSE:NOVO B
44.1
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.4
-20%
US
Merck & Co Inc
NYSE:MRK
143
7 454%
UK
AstraZeneca PLC
LSE:AZN
37.8
168%
CH
Roche Holding AG
SIX:ROG
15.4
26%
CH
Novartis AG
SIX:NOVN
11.1
15%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -514.9
680%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.